Trial Profile
A Study to Evaluate the Safety, Tolerability, Systemic Pharmacokinetic Profile and Pharmacodynamics of Single and Repeat Inhaled Doses of GSK961081 in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Oct 2021
Price :
$35
*
At a glance
- Drugs Batefenterol (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Adverse reactions
- Sponsors GlaxoSmithKline
- 29 Apr 2009 New trial record